Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122561202 | 12256120 | 2 | F | 201210 | 20160722 | 20160412 | 20160729 | PER | US-PFIZER INC-2016202513 | PFIZER | 60.00 | YR | M | Y | 0.00000 | 20160729 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122561202 | 12256120 | 1 | PS | DEPO-TESTOSTERONE | TESTOSTERONE CYPIONATE | 1 | EVERY 2 TO 3 WEEKS | U | 85635 | SOLUTION FOR INJECTION | |||||||||
| 122561202 | 12256120 | 2 | SS | DEPO-TESTOSTERONE | TESTOSTERONE CYPIONATE | 1 | 200 MG, UNK | U | 85635 | 200 | MG | SOLUTION FOR INJECTION | |||||||
| 122561202 | 12256120 | 3 | SS | TESTOSTERONE. | TESTOSTERONE | 1 | 200 MG | U | 0 | 200 | MG | INJECTION | |||||||
| 122561202 | 12256120 | 4 | SS | TESTOSTERONE. | TESTOSTERONE | 1 | U | 0 | INJECTION | ||||||||||
| 122561202 | 12256120 | 5 | C | MULTIVITAMIN | VITAMINS | 1 | UNK | 0 | |||||||||||
| 122561202 | 12256120 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 122561202 | 12256120 | 7 | C | MELOXICAM. | MELOXICAM | 1 | UNK | 0 | |||||||||||
| 122561202 | 12256120 | 8 | C | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | UNK | 0 | |||||||||||
| 122561202 | 12256120 | 9 | C | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122561202 | 12256120 | 1 | Hormone replacement therapy |
| 122561202 | 12256120 | 3 | Blood testosterone decreased |
| 122561202 | 12256120 | 4 | Hormone replacement therapy |
| 122561202 | 12256120 | 5 | Routine health maintenance |
| 122561202 | 12256120 | 6 | Gastrooesophageal reflux disease |
| 122561202 | 12256120 | 7 | Osteoarthritis |
| 122561202 | 12256120 | 8 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122561202 | 12256120 | HO |
| 122561202 | 12256120 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122561202 | 12256120 | Deep vein thrombosis | |
| 122561202 | 12256120 | Neuralgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122561202 | 12256120 | 1 | 201008 | 201211 | 0 | |
| 122561202 | 12256120 | 3 | 201008 | 201211 | 0 | |
| 122561202 | 12256120 | 5 | 1991 | 0 | ||
| 122561202 | 12256120 | 6 | 200401 | 0 | ||
| 122561202 | 12256120 | 7 | 201207 | 201508 | 0 | |
| 122561202 | 12256120 | 8 | 200704 | 200807 | 0 | |
| 122561202 | 12256120 | 9 | 201102 | 201212 | 0 |